Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02993276 · ClinicalTrials.gov registry record
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
A clinical trial of Neuroma, sponsored by Polyganics.
- Completed
- Registry status
- 73
- Enrollment target
- 16
- Study locations
NCT02993276: Completed study of Neuroma, sponsored by Polyganics.
NCT02993276 is a study of Neuroma that has completed, run by Polyganics. The registered enrollment target is 73 participants. The trial reports 16 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02993276, a study of Neuroma, has completed, sponsored by Polyganics.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
- 16
- Study locations
Study Summary
PROSPECTIVE COHORT EVALUATION OF NEUROCAP® In the Treatment of symptomatic Neuroma (PROTECT Neuro) This post-market surveillance study is conducted to provide post market surveillance information regarding long-term performance and ease of use of the Polyganics nerve capping device (NEUROCAP®) for reduction of the development of peripheral symptomatic end-neuroma.
Primary Outcome
Subjective pain score as indicated by the patient on a scale of 1-100.
Conditions Studied
Interventions
- DEVICE Neurocap®
Study Locations (16)
Other
- Clinique Chirurgicale Victor Hugo Paris - Paris
- BG Trauma Center Frankfurt am Main GmbH - Frankfurt am Main
- Ospedale San Guiseppe Milano - Milan
- Parc Sanitari Sant Joan de Deu - Barcelona
- Sahlgrenska University Hospital Gothenburg - Gothenburg
- University Hospital Linköping - Linköping
- University Hospital Lund - Department of Hand Surgery - Malmo
- Birmingham Hand Centre - Birmingham
Pennsylvania
- Geisinger Clinic - Danville
- University of Pennsylvania - Philadelphia
- The Philadelphia Hand Center (affiliated to Thomas Jefferson Hospital) - Philadelphia
California
- Stanford Medical Center Hand and Upper Limb Center - Redwood City
- Buncke Clinic - San Francisco
Arizona
- Arizona Center for Hand Surgery - Phoenix
Oregon
- Veterans affairs Medical Center Portland - Portland
Virginia
- Virginia Commonwealth University Medical Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2020-08-30 |
What the finished NCT02993276 record still lists
NCT02993276 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 1 condition, with Neuroma appearing as the primary indexed condition, and to 1 intervention - of which Neurocap® is the first listed.
NCT02993276 lists 16 locations in 6 states (Other, Pennsylvania, California).
Frequently Asked Questions
What is clinical trial NCT02993276 about?
NCT02993276 is a clinical study titled "Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma". PROSPECTIVE COHORT EVALUATION OF NEUROCAP® In the Treatment of symptomatic Neuroma (PROTECT Neuro) This post-market surveillance study is conducted to provide post market surveillance information regarding long-term performance and ease of use of the Polyganics nerve capping device (NEUROCAP®) for ...
What is the current status of trial NCT02993276?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2017-04-17. Estimated completion is 2020-08-30.
What conditions does trial NCT02993276 study?
This clinical trial studies the following conditions: Neuroma.
What interventions are being tested in trial NCT02993276?
The interventions under investigation include: Neurocap® (DEVICE).
Who is sponsoring clinical trial NCT02993276?
This trial is sponsored by Polyganics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02993276 being conducted?
This trial has 16 study locations across Arizona, California, Oregon, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuroma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI